117666-31-6

Upstream product

• 106-95-6 allyl bromide 
• 117708-89-1 (1R,2S,3R,4S,5S,6R)-3,4,6-Tris-allyloxy-5-benzyloxy-cyclohexane-1,2-diol 
• 111392-09-7 (1S,2R,3S,4R,5R,6S)-3,4,6-Tris-allyloxy-5-benzyloxy-cyclohexane-1,2-diol 
• 33021-17-9 (-)-2,3:4,5-di-O-cyclohexylidene-myo-inositol 
• 145789-54-4 (-)-3,4,5-tri-O-allyl-6-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 145789-53-3 (+)-3,4-di-O-allyl-1,2:5,6-di-O-cyclohexylidene-myo-inositol 
• 139978-97-5 (+)-3,4-di-O-allyl-6-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 139978-96-4 (+)-3,4-di-O-allyl-1,2-O-cyclohexylidene-myo-inositol 
• 6763-49-1 (+/-)-1,2:5,6-dicyclohexylidene-myo-inositol 
• 117666-29-2 (+/-)-3,6-di-O-allyl-4-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 112204-05-4 (+/-)-3,6-di-O-allyl-1,2-O-cyclohexylidene-myo-inositol 
• 140148-49-8 (-)-3,4,5-tri-O-allyl-6-O-benzyl-myo-inositol 
• 818-08-6 di(n-butyl)tin oxide 
• 101636-71-9 1,6-Di-O-acetyl-2,3:4,5-di-O-cyclohexylidene-D/L-myo-inositol 

Downstream Products

• 115015-97-9 (-)-1L-2,6-di-O-benzyl-myo-inositol 
• 117666-30-5 (+)-1,3,4,5-tetra-O-allyl-2,6-di-O-benzyl-myo-inositol 

Relevant academic research and scientific papers

AN EFFICIENT ROUTE TO D-MYO-INOSITOL 1,3,4-TRIPHOSPHATE AND D-MYO-INOSITOL 1,3,4,5-TETRAKISPHOSPHATE

Multigram quantities of the title compounds in their enantiomerically-pure forms have been prepared by employing a chiral precursor which can be obtained via a facile enzymatic process.

An efficient chemoenzymic access to optically active myo-inositol polyphosphates

The 1,4,5-tris-, 1,3,4-tris-, and 1,3,4,5-tetrakis-phosphates of 1D-myo-inositol have been prepared in their enantiomerically pure forms from the two enantiomers of 1,2:5,6-di-O-cyclohexylidene-myo-inositol. A facile enzymic preparation is also described

TOTAL SYNTHESIS OF OPTICALLY ACTIVE MYO-INOSITOL 1,4,5-TRISPHOSPHATE AND MYO-INOSITOL 1,3,4,5-TETRAKISPHOSPHATE

A convenient approach to the preparation of the title compounds illustrating selective protection, optical resolution and phosphorylation is presented.